1992
DOI: 10.1002/j.1552-4604.1992.tb03856.x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic Characterization of the Postdistribution Phase of Prohormone Atrial Natriuretic Peptides Amino Acids 1–98, 31–67, and Atrial Natriuretic Factor During and After Rapid Right Ventricular Pacing in Dogs

Abstract: Release rate constants and disappearance rate constants were determined for three atrial natriuretic peptides consisting of amino acids 1-98 (i.e., proANF 1-98), the midportion of the ANF prohormone consisting of amino acids 31-67 (i.e., proANF 31-67) and amino acids 99-126 (i.e., ANF) after right ventricular pacing at 100, 125, 150, and 180 bpm in six male mongrel dogs. Right atrial and femoral vein blood was obtained at baseline, and at 5, 12, 19, 26, 56, 86, 116, 146, and 206 minutes after right ventricular… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

1995
1995
2001
2001

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 27 publications
1
21
0
Order By: Relevance
“…The control subjects received vehicle only, but otherwise adhered to an identical pro¬ tocol of a 1-h equilibration period followed by a 1-h infusion period with a 3-h recovery period of evaluation. One hundred nanograms per kilogram body weight per minute was chosen for the infusion dosage of the atrial natriuretic peptides because the rate of release of the N-terminal ANF prohormone peptides from the atrium of the heart with physiological stimuli is 138-292 ng/kg body wt per min, whereas the release rate of ANF from the atrium is 76 ng/kg body wt per min (Ackerman et al 1992). Molar equivalents of 100 ng/kg body wt dose are 32, 29, 26 and 46 pmol/kg body wt for ANF, proANFs 1-30, 31-67 and 79-98 respectively.…”
Section: Methodsmentioning
confidence: 99%
“…The control subjects received vehicle only, but otherwise adhered to an identical pro¬ tocol of a 1-h equilibration period followed by a 1-h infusion period with a 3-h recovery period of evaluation. One hundred nanograms per kilogram body weight per minute was chosen for the infusion dosage of the atrial natriuretic peptides because the rate of release of the N-terminal ANF prohormone peptides from the atrium of the heart with physiological stimuli is 138-292 ng/kg body wt per min, whereas the release rate of ANF from the atrium is 76 ng/kg body wt per min (Ackerman et al 1992). Molar equivalents of 100 ng/kg body wt dose are 32, 29, 26 and 46 pmol/kg body wt for ANF, proANFs 1-30, 31-67 and 79-98 respectively.…”
Section: Methodsmentioning
confidence: 99%
“…By comparing figures 4 and 5, one observes that pro-ANF 1-98 is doubling, while the kaliuretic peptide concentration is increasing sixfold, and the pro-ANF 69-98 concentration is not significantly increasing with im mersion. Pro-ANF 1-98 has a half-life 15-fold longer than ANF [30], Consequently, clearance from the circulation of pro-ANF 1-98 partially accounts for the observation that when immersion ceases, ANF returned to normal within 1 h, whereas the peptides immunologically recog nized by the kaliuretic peptide radioimmunoassay were still significantly elevated. The FIP-GPC data ( fig.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, one group (control group or sham infusion) received only 20 ml normal saline without any of the peptide hormones, and the other four groups received one of the respective peptide hormones in 20 ml normal saline. One hundred nanograms per kg BW/min was chosen for the infusion of these ANPs, because the rate of release of the N-terminal ANH prohormone peptides from the atrium of dog heart with physiological stimuli is 138 -292 ng/kg BW⅐min, whereas the release rate of ANH is 76 ng/kg BW⅐min (15). All subjects were studied in the morning after an overnight fast, beginning their baseline period at 0800 h. Each volunteer was studied in the seated position and received only one peptide hormone infusion.…”
Section: Experimental Protocolmentioning
confidence: 99%